CorFlow secures $48.5m for microvascular obstruction detection device
CorFlow Therapeutics has raised $48.5m (€44m) in a Series B financing round to advance its microvascular obstruction (MVO) detection device…
Cardiovascular
-
-
Abbott rolls out AVEIR DR leadless pacemaker across UK
Abbott will roll out its AVEIR dual chamber (DR) leadless pacemaker system across the UK, to treat patients with abnormal…
-
Renata Medical implants Minima Growth Stent in first patient
Renata Medical has announced the successful implantation of the Minima Growth Stent in a patient, marking the first use since…
-
ESC 2024: Elixir’s stent contender hits primary endpoint in CAD trial
Elixir Medical’s DynamX Bioadaptor scaffold for coronary artery disease (CAD) has produced positive results in a randomised controlled trial comparing…
-
Study identifies blood biomarkers for predicting 30-year heart risks
A study sponsored by the US National Institutes of Health (NIH) has found that measuring three blood biomarkers can be…
-
Abbott expands Heartmate 3’s FDA label to eliminate aspirin use
The US Food and Drug Administration (FDA) has approved a label change for Abbott’s HeartMate 3 left ventricular assist device,…
-
Johnson & Johnson to acquire cardiovascular specialist V-Wave for up to $1.7bn
Johnson & Johnson (J&J) will acquire heart failure implant company V-Wave in a deal worth a potential $1.7bn, marking the…
-
Jupiter Endovascular emerges with $21m for endoportal pivotal trial
Jupiter Endovascular has emerged from stealth with $21m in new financing as the company looks to forge its new type…
-
FDA recalls incorrectly dispatched J&J’s Abiomed heart pumps
Abiomed has been forced to issue yet another recall for its heart pumps after nine pumps from a failed inspection…
-
SyMap wins approval for renal denervation system in China
Chinese company SyMap Medical has received a Class III medical device approval for its msRDN selective renal denervation system from…
